Hong Kong, China

Chun Wai Davy Lee

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: British Columbia Cancer Agency Branch, Versitech, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chun Wai Davy Lee. Retrieved from https://idiyas.com/inventor/chun-wai-davy-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Chun Wai Davy Lee

Introduction

Chun Wai Davy Lee is a notable inventor based in China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-influenza compounds. His work focuses on creating effective treatments for influenza and other related diseases.

Latest Patents

Chun Wai Davy Lee holds a patent for Anti-Influenza Compounds. The present invention provides pyrimidinyl compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds may be used for the inhibition of influenza, specifically targeting influenza A, including H1N1 and H5N1 strains. Additionally, the compounds can be utilized for the treatment or prophylaxis of diseases caused by various pathogens, including Vibrio cholerae and Clostridium perfringens.

Career Highlights

Throughout his career, Chun Wai Davy Lee has focused on innovative solutions in the pharmaceutical industry. His research has contributed to advancements in the treatment of viral infections, showcasing his commitment to public health.

Collaborations

Chun Wai Davy Lee has collaborated with notable colleagues, including Allan Sik-Yin Lau and Hing Yee Law. These partnerships have enhanced the scope and impact of his research efforts.

Conclusion

Chun Wai Davy Lee's work in developing anti-influenza compounds highlights his dedication to addressing critical health challenges. His contributions to the field of pharmaceuticals are significant and continue to influence future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…